Postdoctoral Position in Pet Imaging in Diabetes and Oncology

Applicants are invited to apply for a postdoctoral researcher position in molecular imaging at Uppsala University, Sweden. Applicants should apply before March 01, 2019.

The aim of the project is to develop and evaluate PET radiopharmaceuticals for in vivo molecular imaging of inflammatory processes and beta cell mass. The radiopharmaceuticals will be used to study disease processes in models of diabetes and cancer. The radiopharmaceutical development may include radiolabeling/ radiochemistry, in vitro evaluation (cells and autoradiography) and in vivo evaluation (PET imaging, image analysis, biodistribution and dosimetry). Apart from research, the postdoc may participate in teaching and routine maintenance of the lab.

We welcome applications from candidates that already have, or who expect to soon have, a PhD degree in biomedicine, engineering, chemistry, natural sciences, pharmacy, medicine or similar, completed a maximum of three (3) years before the final application date. During certain circumstances, an earlier PhD can be acceptable. Certain circumstances include leave due to illness, maternity leave, in trade unions, etc.

Experience of laboratory work including radiochemistry, in vitro (cells/ autoradiography) and in vivo (biodistribution, PET/SPECT/CT/MRI imaging, image analysis) evaluation of radiopharmaceuticals is a strong advantage. Completed courses in laboratory animal science (e.g. FELASA C) or radiation protection are an advantage. The applicant must be fluent in English with excellent communication skills.


More scholarships: postdoc position in molecular imaging, postdoc position in pharmacy, postdoc position in diabetes, molecular imaging postdoc position, pharmacy postdoc position, diabetes postdoc position, postdoc position in sweden, postdoc position at uppsala university

Get latest scholarships via your email! It's free!
Remember to check your email and active the subscription.
You can unsubscribe any time.
Copyright © 2019 All Right Reserved.